Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 05, 2021

SELL
$157.07 - $174.35 $5.36 Million - $5.95 Million
-34,100 Closed
0 $0
Q3 2020

Oct 29, 2020

BUY
$137.1 - $165.37 $246,780 - $297,666
1,800 Added 5.57%
34,100 $5.64 Million
Q2 2020

Aug 10, 2020

SELL
$111.92 - $142.53 $917,744 - $1.17 Million
-8,200 Reduced 20.25%
32,300 $4.43 Million
Q1 2020

Apr 30, 2020

SELL
$92.66 - $144.94 $185,320 - $289,880
-2,000 Reduced 4.71%
40,500 $4.77 Million
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $453,375 - $519,675
-3,900 Reduced 8.41%
42,500 $5.62 Billion
Q3 2019

Nov 04, 2019

BUY
$112.57 - $128.43 $382,738 - $436,662
3,400 Added 7.91%
46,400 $5.78 Million
Q1 2019

May 14, 2019

BUY
$81.56 - $100.67 $570,920 - $704,690
7,000 Added 19.44%
43,000 $0
Q4 2017

Feb 12, 2018

BUY
$63.24 - $72.8 $2.28 Million - $2.62 Million
36,000
36,000 $0

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Aubrey Capital Management LTD Portfolio

Follow Aubrey Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aubrey Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aubrey Capital Management LTD with notifications on news.